Survey Shows American Psychologists Still Don’t Really Understand Psychedelics
ResearchLess than half of psychologists surveyed agreed that psychedelics showed promise in the treatment of serious mental health issues.
Psyched Wellness to Study Amanita Muscaria Mushroom Extract for Sleep Disorders
ResearchPsychoactive compound muscimol has been shown to treat stress and anxiety, ease muscular pain, and promote restorative sleep.
Tim Ferriss and Michael Pollan Team Up to Launch UC Berkeley Psychedelic Journalism Fellowship
ResearchPodcaster and author of "The 4-Hour Work Week" will gift the university's Center for the Science of Psychedelics $800,000 over 3 years to fund fellowship overseen by Professor Pollan.
UW-Madison Study Aims to Increase Minority Representation in Psychedelic Clinical Trials
Research"Certain demographic groups have been the recipients of more legal scrutiny related to substance use than the majority of the population,” says lead researcher Cody Wenthur.
Algernon Pharmaceuticals Shows DMT Can Increase Neuron Growth by 40%
ResearchThe Vancouver-based drug development company is investigating the use of DMT as a possible treatment for stroke.
Mindset Pharma’s DMT-Inspired Drug Candidates Could Address Serotonin Syndrome Challenge
Business, Research“The data suggests that we have a new drug that may be at least as effective, if not more effective, than 5-MeO-DMT and, more importantly, it looks like it is much safer," says Mindset Pharma CEO James Lanthier.
Scientists Begin Exploring Therapeutic Potential of Psilocybin Mushrooms Native to Australia
Research“Australian native ‘magic mushrooms’ may have evolved different methods for psilocybin production and offer adaptations that are preferential for use in clinical treatments," explains University of Queensland mycologist Dr. Alistair McTaggart.
University of Wisconsin-Madison Launches New Psychedelic Research Center
ResearchThis school offers the first accredited American degree focused on the study and therapeutic development of psychedelic compounds and related psychoactive drugs.
Psychedelics May Decrease Racial Trauma Symptoms Among People of Color
ResearchStudy authors write, "Results showed significant and large reductions in the intensity of traumatic stress, depression, and anxiety symptoms from the 30 days before to the 30 days after a referent psychedelic experience."
Johns Hopkins and Mydecine Partner to Further Psychedelic Therapy for Smoking Addiction
Research“Cigarette smoking remains one of the most difficult addictions to treat and contributes to more deaths than all the other substances combined, making this research vital," says Mydecine Innovations Chief Medical Officer Dr. Rakesh Jetly.